Differential binding of platelet-derived growth factor isoforms to glycosaminoglycans

被引:34
作者
García-Olivas, R
Hoebeke, J
Castel, S
Reina, M
Fager, G
Lustig, F
Vilaró, S
机构
[1] Univ Barcelona, Fac Biol, Dept Cellular Biol, E-08028 Barcelona, Spain
[2] Inst Biol Mol & Cellulaire, CNRS, UPR9021, F-67084 Strasbourg, France
[3] Sahlgrens Univ Hosp, Wallenberg Lab Cardiovasc Res, S-41345 Gothenburg, Sweden
关键词
PDGF; LPL; heparan sulfate; chondroitin sulfate; dermatan sulfate; heparin; CHO;
D O I
10.1007/s00418-003-0576-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The platelet-derived growth factor (PDGF) family comprises disulfide-bonded dimeric isoforms and plays a key role in the proliferation and migration of mesenchymal cells. Traditionally, it consists of homo- and heterodimers of A and B polypeptide chains that occur as long (A(L) and B-L) or short (A(S) and B-S) isoforms. Short isoforms lack the basic C-terminal extension that mediates binding to heparin. In the present study, we show that certain PDGF isoforms bind in a specific manner to glycosaminoglycans (GAGs). Experiments performed with wild-type and mutant Chinese hamster ovary cells deficient in the synthesis of GAGs revealed that PDGF long isoforms bind to heparan sulfate and chondroitin sulfate, while PDGF short isoforms only bind to heparan sulfate. This was confirmed by digestion of cell surface GAGs with heparitinase and chondroitinase ABC and by incubation with sodium chloride to prevent GAG sulfation. Furthermore, exogenous GAGs inhibited the binding of long isoforms to the cell membrane more efficiently than that of short isoforms. Additionally, we performed surface plasmon resonance experiments to study the inhibition of PDGF isoforms binding to low molecular weight heparin by GAGs. These experiments showed that PDGF-AA(L) and PDGF-BBS isoforms bound to GAGs with the highest affinity. In conclusion, PDGF activity at the cell surface may depend on the expression of various cellular GAG species.
引用
收藏
页码:371 / 382
页数:12
相关论文
共 53 条
[1]  
ANDERSSON M, 1994, J BIOL CHEM, V269, P926
[2]  
[Anonymous], 1990, CONFOCAL MICROSCOPY
[3]   BASIC FIBROBLAST GROWTH-FACTOR BINDS TO SUBENDOTHELIAL EXTRACELLULAR-MATRIX AND IS RELEASED BY HEPARITINASE AND HEPARIN-LIKE MOLECULES [J].
BASHKIN, P ;
DOCTROW, S ;
KLAGSBRUN, M ;
SVAHN, CM ;
FOLKMAN, J ;
VLODAVSKY, I .
BIOCHEMISTRY, 1989, 28 (04) :1737-1743
[4]   ANTIPROLIFERATIVE ACT MUSCLE-CELLS AND RECEPTOR-BINDING OF HEPARIN-MIMICKING POLYAROMATIC ANIONIC COMPOUNDS [J].
BENEZRA, M ;
BENSASSON, SA ;
REGAN, J ;
CHANG, M ;
BARSHAVIT, R ;
VLODAVSKY, I .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (12) :1992-1999
[5]  
BENGTSSONOLIVECRONA G, 1991, METHOD ENZYMOL, V197, P345
[6]   PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor [J].
Bergsten, E ;
Uutela, M ;
Li, XR ;
Pietras, K ;
Östman, A ;
Heldin, CH ;
Alitalo, K ;
Eriksson, U .
NATURE CELL BIOLOGY, 2001, 3 (05) :512-516
[7]   HEPARAN-SULFATE PROTEOGLYCANS ARE PRIMARILY RESPONSIBLE FOR THE MAINTENANCE OF ENZYME-ACTIVITY, BINDING, AND DEGRADATION OF LIPOPROTEIN-LIPASE IN CHINESE-HAMSTER OVARY CELLS [J].
BERRYMAN, DE ;
BENSADOUN, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (41) :24525-24531
[8]   Inhibition of neointimal formation by natural heparan sulfate proteoglycans of the arterial wall [J].
Bingley, JA ;
Campbell, JH ;
Hayward, IP ;
Campbell, GR .
ATHEROSCLEROSIS IV: RECENT ADVANCES IN ATHEROSCLEROSIS RESEARCH: THE FOURTH SARATOGA INTERNATIONAL CONFERENCE ON ATHEROSCLEROSIS, 1997, 811 :238-244
[9]   Growth factors released into the coronary circulation after vascular injury promote proliferation of human vascular smooth muscle cells in culture [J].
Caplice, NM ;
Aroney, CN ;
Bett, JHN ;
Cameron, J ;
Campbell, JH ;
Hoffmann, N ;
McEniery, PT ;
West, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (07) :1536-1541
[10]  
Casaroli-Marano RP, 1998, J LIPID RES, V39, P789